Zemdri
1 known investors
Find your way into Zemdri
Sign up to see every warm intro you have to Zemdri
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Zemdri team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ZEMDRI (plazomicin) is an aminoglycoside antibiotic injection indicated for adults with complicated urinary tract infections, including pyelonephritis, caused by certain susceptible microorganisms. The product is a prescription pharmaceutical marketed by Cipla Therapeutics.
Investors · 1
Frequently asked questions
- What does Zemdri do?
- ZEMDRI (plazomicin) is an aminoglycoside antibiotic injection indicated for adults with complicated urinary tract infections, including pyelonephritis, caused by certain susceptible microorganisms. The product is a prescription pharmaceutical marketed by Cipla Therapeutics.
- Who are Zemdri's investors?
- Zemdri's investors include Frazier Life Sciences.